Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Clin Lung Cancer. 2021 Oct 10;23(1):60–71. doi: 10.1016/j.cllc.2021.10.002

Figure 1:

Figure 1:

CONSORT S0819 trial profile. Eligible patients are dichotomized by treatment arm and further subdivided by assay conducted. Parentheses indicate the subset that is SCC within each group. (n: number of patients; EGFR: epidermal growth factor receptor; FISH: fluorescence in situ hybridization; H-Score: immunohistochemistry score; SCC: squamous cell carcinoma)